Clinical Trials Browser

Interventional × Liver Diseases × pembrolizumab × Clear all

NCT06600321 2026-06-01

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Phase 1 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms